Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Abdominal Radiology
Published in: Abdominal Radiology 5/2016

01-05-2016 | Pictorial Essay

A practical primer on PI-RADS version 2: a pictorial essay

Authors: Gary Lloyd Horn Jr., Peter Florin Hahn, Shahin Tabatabaei, Mukesh Harisinghani

Published in: Abdominal Radiology | Issue 5/2016

Login to get access

Abstract

Multiparametric magnetic resonance imaging has become an established method for evaluating the prostate for clinically significant prostate adenocarcinoma. Criteria have been developed for categorizing MRI findings, the most frequently used of which is the PI-RADS system. The PI-RADS V2 document provides separate image interpretation and clinical grading sections. Within this article we give an overview of the integrated, algorithmic way, we approach prostate MRI, show images corresponding to each PI-RADS category, and provide several illustrative cases.
Literature
1.
2.
Vargas HA, Hotker AM, Goldman DA, et al. (2015) Updated prostate imaging reporting and data system (PIRADS v2) recommendations for the detection of clinically significant prostate cancer using multiparametric MRI: critical evaluation using whole-mount pathology as standard of reference. Eur Radiol. doi:10.​1007/​s00330-015-4015-6
3.
Zhang ZX, Yang J, Zhang CZ, et al. (2014) The value of magnetic resonance imaging in the detection of prostate cancer in patients with previous negative biopsies and elevated prostate-specific antigen levels: a meta-analysis. Acad Radiol 21(5):578–589. doi:10.​1016/​j.​acra.​2014.​01.​004 CrossRefPubMed
4.
5.
6.
7.
Puech P, Rouviere O, Renard-Penna R, et al. (2013) Prostate cancer diagnosis: multiparametric MR-targeted biopsy with cognitive and transrectal US-MR fusion guidance versus systematic biopsy–prospective multicenter study. Radiology 268(2):461–469. doi:10.​1148/​radiol.​13121501 CrossRefPubMed
8.
Metadata
Title
A practical primer on PI-RADS version 2: a pictorial essay
Authors
Gary Lloyd Horn Jr.
Peter Florin Hahn
Shahin Tabatabaei
Mukesh Harisinghani
Publication date
01-05-2016
Publisher
Springer US
Published in
Abdominal Radiology / Issue 5/2016
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-016-0705-z

Other articles of this Issue 5/2016

Abdominal Radiology 5/2016 Go to the issue

Commentary

Engaging and educating patients in prostate imaging via social media

Commentary

Commentary regarding the inter-reader reproducibility of PI-RADS version 2

OriginalPaper

The expanding landscape of diffusion-weighted MRI in prostate cancer

OriginalPaper

Practical aspects of prostate MRI: hardware and software considerations, protocols, and patient preparation

Invited Article

Targeted prostate biopsy and MR-guided therapy for prostate cancer

OriginalPaper

Multiparametric prostate MRI: focus on T2-weighted imaging and role in staging of prostate cancer
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits